AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 17108797
Drug: Therapeutic taping
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic taping + physical therapy
Trial: 15346082
Drug: Both implants
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both implants (LISS and distal femoral nail)
Trial: 3902379
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg bezafibrate per day
Trial: 3902379
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg fenofibrate per day
Trial: 22242678
Drug: Desloratadine 5
RxNorm normalized name: desloratadine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desloratadine 5 mg daily for 6 weeks (Control)
Trial: 22242678
Drug: Escalating doses
RxNorm normalized name: peanut allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escalating doses of desloratadine: 5 mg daily for the first 2 weeks, 10 mg daily for the second 2 weeks, and 20 mg daily for the final 2 weeks (Intervention)
Trial: 18408525
Drug: Venlafaxine ER
RxNorm normalized name: Venlafaxine ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine ER 75 mg/day (up to 300 mg/day)
Trial: 18408525
Drug: Citalopram 20
RxNorm normalized name: citalopram 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram 20 mg/day (up to 60 mg/day)
Trial: 15741037
Drug: No cold
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No cold therapy (control)
Trial: 10420136
Drug: 0.16% RBG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.16% RBG cream
Trial: 2147235
Drug: Imipramine (dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine (dose adjusted to optimal plasma levels of 400-600 nM)
Trial: 6988039
Drug: 100 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 micrograms inhaled salbutamol powder
Trial: 6988039
Drug: 400 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 micrograms inhaled salbutamol powder
Trial: 6988039
Drug: 800 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 micrograms inhaled salbutamol powder
Trial: 30334096
Drug: GLE/PIB treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GLE/PIB treatment for 12 weeks
Trial: 28350758
Drug: Vaginal gel
RxNorm normalized name: VAGINAL GEL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal gel containing 50μg estriol for 12 weeks (group A)
Trial: 28350758
Drug: Estriol vaginal
RxNorm normalized name: estriol Vaginal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estriol vaginal gel after surgery (group A1)
Trial: 28350758
Drug: No estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No estrogen treatment (group B)
Trial: 28350758
Drug: Estriol treatment
RxNorm normalized name: Estriol
DrugBank: Estriol (DB04573)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estriol treatment after surgery (group A1)
Trial: 28350758
Drug: No estriol
RxNorm normalized name: Estriol
DrugBank: Estriol (DB04573)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No estriol treatment after surgery (group A2)
Trial: 25293727
Drug: Chemotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy with external beam radiotherapy (EBRT) (45-50.4 Gy)
Trial: 25293727
Drug: Chemotherapy without
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chemotherapy without external beam radiotherapy (EBRT)
Trial: 25293727
Drug: Chemotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy with pre-anastomosis intraoperative electron radiation therapy (IOERT) boost (10-15 Gy)
Trial: 25293727
Drug: Chemotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy with external beam radiotherapy (EBRT)
Trial: 23803042
Drug: Ginger supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginger supplement (750 mg per capsule, 4 capsules daily for 6 weeks)
Trial: 23803042
Drug: Water-based exercise
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Water-based exercise + Ginger supplement
Trial: 22292254
Drug: Hyperbaric oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric oxygen therapy (HBO2), initiated within 1-3 days post-surgery, for at least 20 sessions (one session per day)
Trial: 16725234
Drug: Combined hepatitis
RxNorm normalized name: hepatitis nosodes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined hepatitis A/B vaccine Twinrix (GSK)
Trial: 16725234
Drug: Co-administered hepatitis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-administered hepatitis A vaccine, Havrix (GSK) + hepatitis B vaccine Engerix-B (GSK)
Trial: 16725234
Drug: Co-administered hepatitis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-administered hepatitis A vaccine, Vaqta (Sanofi-Pasteur MSD) + hepatitis B vaccine HB VAX PRO (Sanofi-Pasteur MSD)
Trial: 11479155
Drug: Patients with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients with serum creatinine > 6 mg/dL (12 patients)
Trial: 11479155
Drug: MHD patients
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MHD patients with therapy longer than 10 years (8 patients)
Trial: 10096818
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (Gortex bags, high-powered vacuum cleaner, benzyl alcohol and tannic acid spray)
Trial: 10096818
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment (light cotton bags, cheap vacuum cleaner, water spray)
Trial: 7995325
Drug: 17 beta-oestradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17 beta-oestradiol (9 mg)
Trial: 30712745
Drug: 2% lavender
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% lavender essential oil inhalation for 20 minutes every night for one month
Trial: 30712745
Drug: Placebo (distilled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (distilled water) inhalation for 20 minutes every night for one month
Trial: 28584187
Drug: adalimumab (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: adalimumab (40 mg every 2 weeks)
Trial: 24934402
Drug: MAT-Fel d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MAT-Fel d 1 vaccine
Trial: 17868757
Drug: Measurement-based treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Measurement-based treatment protocols
Trial: 31480601
Drug: Pregabalin (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin (oral solution of pregabalin 150 mg twice daily for 14 days)
Trial: 27876198
Drug: Monovalent rotavirus
RxNorm normalized name: rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monovalent rotavirus vaccine (RV1)
Trial: 20152998
Drug: Metformin +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin + GLP-1
Trial: 9244203
Drug: Azithromycin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin (500 mg/d for 3 days or 500 mg/d for 6 days)
Trial: 8310466
Drug: Long-term outpatient
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term outpatient treatment in alcoholics with previous suicidal behavior
Trial: 2939574
Drug: Alcuronium 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcuronium 0.25 mg/kg
Trial: 30202946
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of omega-3 and losartan
Trial: 25735918
Drug: Bemfola (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bemfola (150 IU daily)
Trial: 25735918
Drug: Gonal-f (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gonal-f (150 IU daily)
Trial: 23967725
Drug: Capecitabine conjugated
RxNorm normalized name: Capecitabine
DrugBank: Capecitabine (DB01101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Capecitabine conjugated with a new biological agent
Trial: 3068160
Drug: Piroxicam (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piroxicam (20 mg) + Rosaprostol (2 g) daily
Trial: 3068160
Drug: Piroxicam (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piroxicam (20 mg) + Placebo
Trial: 3068160
Drug: NSAIDs (diclofenac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NSAIDs (diclofenac sodium 50 mg, piroxicam 20 mg, acetylsalicylic acid 500 mg)
Trial: 3068160
Drug: Rosaprostol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosaprostol (2 g)
Trial: 28937272
Drug: Movement music
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Movement music therapy (MMT) group, 35 participants
Trial: 27627596
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (oral hygiene education only)
Trial: 21599573
Drug: 150 ml
RxNorm normalized name: REBYOTA 150 ML Enema
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 ml of red wine/day for women (16 g ethanol/day) or 300 ml of red wine/day for men (33 g ethanol/day)
Trial: 16766434
Drug: Conjugated estrogens/medroxyprogesterone
RxNorm normalized name: Conjugated Estrogens/Medroxyprogesterone Acetate 0.625 MG-5 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conjugated estrogens/medroxyprogesterone acetate (CE/MPA) doses: 0.625/2.5, 0.45/1.5, or 0.3/1.5 mg daily for 24 weeks
Trial: 8904521
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human erythropoietin (rhEPO) 300 U kg‐1, i.v. or s.c., once, combined with parenteral and oral iron
Trial: 8904521
Drug: Iron therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron therapy only
Trial: 2125737
Drug: Lithium carbonate
RxNorm normalized name: Lithium Carbonate
DrugBank: Lithium carbonate (DB14509)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lithium carbonate (mean daily dose of 587 +/- 49 mg)
Trial: 6998597
Drug: 30 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg/kg of methylprednisolone sodium succinate (MPN)
Trial: 6998597
Drug: 15 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg/kg of mannitol placebo (PL)
Trial: 31056884
Drug: Oral Alprazolam
RxNorm normalized name: Alprazolam
DrugBank: Alprazolam (DB00404)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral Alprazolam tablets once a day
Trial: 28356271
Drug: Cashew diet
RxNorm normalized name: Cashew
DrugBank: Cashew (DB10653)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cashew diet (28-64 g/d)
Trial: 21736808
Drug: Dried plum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dried plum (100 g/d)
Trial: 7956622
Drug: Daytime insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Daytime insulin infusion (mean 1.5 +/- 0.1 IU/h)
Trial: 7956622
Drug: Nocturnal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nocturnal insulin infusion (mean 1.5 +/- 0.1 IU/h)
Trial: 7956622
Drug: Nocturnal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nocturnal insulin infusion
Trial: 7956622
Drug: Daytime insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Daytime insulin infusion
Trial: 3597264
Drug: Inspiratory resistive
RxNorm normalized name: respiratory syncytial virus pre-fusion F protein Injection [Arexvy]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inspiratory resistive loads (8.9‐35.7 cmH2O X l‐1 X s)
Trial: 27759857
Drug: Topical squalamine
RxNorm normalized name: Squalane
DrugBank: Squalane (DB11420)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical squalamine and intravitreal ranibizumab 0.5 mg
Trial: 27759857
Drug: Ranibizumab 0.5
RxNorm normalized name: RANIBIZUMAB 0.5MG/0.05ML INJ,OPH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranibizumab 0.5 mg (control)
Trial: 25045235
Drug: Intravenous ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ketamine infusion during general anesthesia
Trial: 25045235
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline equivalent to ketamine infusions
Trial: 15259481
Drug: 2 doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 doses of 10 mg/kg triclabendazole
Trial: 15259481
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of 10 mg/kg triclabendazole
Trial: 10223765
Drug: Combined adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined adjuvant chemotherapy and radiotherapy
Trial: 1403921
Drug: 3 mm
RxNorm normalized name: Adapta-Cap G, 33 mm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mm access preparations wetted with mercury-rich amalgam before restoration
Trial: 1403921
Drug: 3 mm
RxNorm normalized name: Adapta-Cap G, 33 mm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mm access preparations restored unwetted
Trial: 3886191
Drug: Amrinone (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amrinone (1.5 mg/kg tid increasing to a maximum dosage of 200 mg tid)
Trial: 26911981
Drug: Lidocaine Injections
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lidocaine Injections (LI)
Trial: 26911981
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Physical Therapy and Lidocaine Injections (PT + LI)
Trial: 20173440
Drug: Acupuncture needling
RxNorm normalized name: NEEDLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture needling treatment and self neck-stretching exercises
Trial: 18243639
Drug: Subcutaneous tetrodotoxin
RxNorm normalized name: Tetrodotoxin
DrugBank: Tetrodotoxin (DB05232)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous tetrodotoxin administered over Days 1-4
Trial: 18243639
Drug: Subcutaneous tetrodotoxin
RxNorm normalized name: Tetrodotoxin
DrugBank: Tetrodotoxin (DB05232)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous tetrodotoxin
Trial: 10397520
Drug: One stage
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One stage full-mouth disinfection treatment
Trial: 10397520
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (scaling and root planing per quadrant at 2-week intervals)
Trial: 8655981
Drug: Nitric oxide
RxNorm normalized name: Nitric Oxide
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nitric oxide (NO) treatment
Trial: 1515957
Drug: Nicardipine (NICAR)
DrugBank: Nicardipine (DB00622)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicardipine (NICAR) 10 micrograms.kg‐1.min‐1 over 10 minutes followed by an infusion at 4 mg.kg‐1.min‐1
Trial: 7124431
Drug: Motipress (combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Motipress (combined anxiolytic/antidepressant)
Trial: 27476789
Drug: Edoxaban 60
RxNorm normalized name: edoxaban 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edoxaban 60 mg once per day (or 30 mg once per day for specific patients)
Trial: 27476789
Drug: Warfarin (dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin (dose adjusted to maintain INR between 2.0 and 3.0)
Trial: 25181622
Drug: Rectally administrated
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rectally administrated 800 mg misoprostol
Trial: 22248028
Drug: β‐elemene at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: β‐elemene at 45 mg/kg
Trial: 19693500
Drug: Dose-dense therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose-dense therapy (CEOP/IMVP-Dexa)
Trial: 19693500
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (CHOP)
Trial: 18584415
Drug: E(2) 2
RxNorm normalized name: (E)-2-butenedioic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E(2) 2 mg/day plus medroxyprogesterone acetate (MPA) 2.5 mg/day
Trial: 18584415
Drug: E(2) 2
RxNorm normalized name: (E)-2-butenedioic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E(2) 2 mg/day
Trial: 18584415
Drug: E(2) 2
RxNorm normalized name: (E)-2-butenedioic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E(2) 2 mg/day plus dienogest 2 mg/day
Trial: 18584415
Drug: E(2) 2
RxNorm normalized name: (E)-2-butenedioic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E(2) 2 mg/day plus norethisterone acetate (NETA) 1 mg/day
Trial: 10206086
Drug: Nisoldipine 5
RxNorm normalized name: nisoldipine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nisoldipine 5 mg alone
Trial: 10206086
Drug: Nisoldipine 5
RxNorm normalized name: nisoldipine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nisoldipine 5 mg with ketoconazole 200 mg (4 days pretreatment and concomitant administration)
Trial: 31955164
Drug: 25-gauge illumination-aided
RxNorm normalized name: GINGI-AID 25 % Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25-gauge illumination-aided scleral buckling (SB) combined with hyaluronate injection after subretinal fluid drainage.
Trial: 31955164
Drug: Conventional SB
RxNorm normalized name: SB 224289
DrugBank: SB 224289 (DB17052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional SB with binocular indirect ophthalmoscope combined with air injection.
Trial: 30865795
Drug: Antibiotics (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics (400 mg oral doxycycline and 400 mg oral metronidazole)
Trial: 28338503
Drug: Crystalline valsartan/sacubitril
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crystalline valsartan/sacubitril (LCZ696) 400 mg daily
Trial: 28338503
Drug: Valsartan 320
RxNorm normalized name: valsartan 320 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan 320 mg daily
Trial: 28338503
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of free valsartan 320 mg and sacubitril 200 mg
Trial: 23871265
Drug: Ketoprofen (3mg/kg)
RxNorm normalized name: Ketoprofen
DrugBank: Ketoprofen (DB01009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketoprofen (3mg/kg) administered intramuscularly for 3 days p.p.
Trial: 21282280
Drug: Rivastigmine patch
RxNorm normalized name: Rivastigmine
DrugBank: Rivastigmine (DB00989)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Rivastigmine patch (9.5 mg/24 hours)
Trial: 21282280
Drug: Rivastigmine capsules
RxNorm normalized name: Rivastigmine
DrugBank: Rivastigmine (DB00989)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Rivastigmine capsules (6 mg twice daily)
Trial: 18463427
Drug: Garlic (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Garlic (0.1 g/kg b.w. daily for 1 month)
Trial: 16415635
Drug: Intensive antihypertensive
RxNorm normalized name: ANTIHYPERTENSIVES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive antihypertensive therapy using fixed-dose combinations of two antihypertensive agents.
Trial: 16415635
Drug: Standard antihypertensive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard antihypertensive therapy (implied control group).
Trial: 8904627
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg butorphanol nasal spray every 6 h
Trial: 8904627
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg cimetidine tablet every 6 h
Trial: 8904627
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of butorphanol nasal spray and cimetidine every 6 h
Trial: 1414906
Drug: 240 mg
RxNorm normalized name: aspirin 240 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 240 mg SR verapamil with a standardized meal
Trial: 1414906
Drug: 240 mg
RxNorm normalized name: aspirin 240 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 240 mg SR verapamil on an empty stomach
Trial: 1414906
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg intravenous verapamil
Trial: 25271117
Drug: Insulin initiation
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin initiation and titration
Trial: 22541308
Drug: Intense rehabilitation
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intense rehabilitation therapies with acupuncture (5 times per week for 12 weeks)
Trial: 22541308
Drug: Intense rehabilitation
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intense rehabilitation therapies without acupuncture (5 times per week for 12 weeks)
Trial: 22541308
Drug: Acupuncture added
RxNorm normalized name: Stahist AD
DrugBank: Chlorcyclizine (DB08936)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acupuncture added to rehabilitation therapies (weeks 16-28)
Trial: 22541308
Drug: Combined groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined groups after intense therapies
Trial: 15632815
Drug: Flexible diuretic
RxNorm normalized name: hydralazine hydrochloride / hydrochlorothiazide / reserpine Oral Tablet [Diuretic Ap-Es]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flexible diuretic titration (DT)